MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Phosphoproteomic Identification of Signaling Pathways
Jump to section
- Article
- Abstract
- Introduction
- Cellular Physiology of AQP2-Expressing Renal Collecting Duct Cells
- Phosphoproteomic Methodology and Bioinformatics
- Effect of Vasopressin on the Phosphoproteome of the Renal Collecting Duct
- Effect of PKA Deletion on the Phosphoproteome of the Renal Collecting Duct
- Identification of Potential PKA Targets by In Vitro Phosphorylation and Mass Spectrometry
- Effect of Kinase Inhibitor H89 on Protein Phosphorylation in PKA-Null Collecting Duct Cells
- Polyuric Disorders: Phosphoproteomics of Lithium-Induced Nephrogenic Diabetes Insipidus
- V2 Receptor Antagonists and Hyponatremic Disorders: How Vaptans Affect the Collecting Duct Phosphoproteome
- Integration of Phosphoproteomic Results
- Authorship Contributions
- Footnotes
- Abbreviations
- References
- Figures & Data
- Info & Metrics
- eLetters
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement